Shanghai INT Medical Instruments Co., Ltd. (HKG: 1501)

Shanghai INT Medical Instruments Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	330.64	423.67	518.27	640.55	870.13	1,037
Short-Term Investments	32.41	10.73	10	-	-	-
Trading Asset Securities	-	-	-	-	71.45	21.4
Cash & Short-Term Investments	363.05	434.4	528.27	640.55	941.59	1,058
Cash Growth	-22.46%	-17.77%	-17.53%	-31.97%	-11.02%	254.90%
Accounts Receivable	74.36	122.92	71.38	78.67	23.66	14.7
Other Receivables	4.37	1.87	2.7	0.91	0.54	0.24
Receivables	78.73	124.79	74.08	79.58	24.19	14.94
Inventory	153.69	128.77	154.28	92.49	55.21	43.42
Other Current Assets	51.77	36.33	45.32	45.81	27.14	7.12
Total Current Assets	647.23	724.29	801.94	858.44	1,048	1,124
Property, Plant & Equipment	909.45	898.28	749.61	564.97	300.17	159.19
Long-Term Investments	195.27	206.47	162.45	130.17	49.06	-
Other Intangible Assets	143.95	20.4	7.16	6.42	5.99	5.9
Long-Term Deferred Tax Assets	17.4	17.65	15.04	9.46	2.15	1.85
Long-Term Deferred Charges	-	109.97	62.77	21.46	1.61	-
Other Long-Term Assets	52.52	52.56	28.37	30.63	15.58	7.98
Total Assets	1,966	2,030	1,827	1,622	1,423	1,299
Accounts Payable	37.24	33.03	36.41	26.99	16.02	16.71
Accrued Expenses	30.05	47.76	37.12	18.92	13.02	14.75
Short-Term Debt	51.54	79.12	32.68	-	-	-
Current Portion of Leases	-	-	0.2	0.19	0.32	0.21
Current Income Taxes Payable	7.5	22.42	12.6	12.22	8.18	6.23
Current Unearned Revenue	32.32	38.62	66.8	36.11	14.8	10.18
Other Current Liabilities	81.16	95.87	53.85	58.8	35.97	11.13
Total Current Liabilities	239.81	316.83	239.67	153.22	88.31	59.2
Long-Term Leases	16.04	15.66	15.94	13.21	1.41	1.62
Long-Term Unearned Revenue	16.46	16.99	10.95	13.7	5.31	3.44
Long-Term Deferred Tax Liabilities	2.42	1.77	6.67	3.5	-	0.03
Total Liabilities	274.72	351.25	273.23	183.63	95.04	64.29
Common Stock	176	171	168	166	166	166
Retained Earnings	560.92	507.5	391.36	303.33	207.68	115.38
Treasury Stock	-40.18	-21.26	-	-	-	-
Comprensive Income & Other	981.91	992	952.65	926.14	931.97	935
Total Common Equity	1,679	1,649	1,512	1,395	1,306	1,216
Minority Interest	12.45	29.14	42.09	42.45	22	17.91
Shareholders' Equity	1,691	1,678	1,554	1,438	1,328	1,234
Total Liabilities & Equity	1,966	2,030	1,827	1,622	1,423	1,299
Total Debt	67.58	94.78	48.83	13.4	1.73	1.83
Net Cash (Debt)	295.48	339.62	479.44	627.15	939.85	1,056
Net Cash Growth	-17.20%	-29.16%	-23.55%	-33.27%	-11.03%	343.88%
Net Cash Per Share	1.75	1.99	2.84	3.76	5.66	8.34
Filing Date Shares Outstanding	176	170.11	168	166	166	166
Total Common Shares Outstanding	176	170.11	168	166	166	166
Working Capital	407.43	407.46	562.28	705.22	959.8	1,064
Book Value Per Share	9.54	9.70	9.00	8.41	7.87	7.33
Tangible Book Value	1,535	1,629	1,505	1,389	1,300	1,210
Tangible Book Value Per Share	8.72	9.58	8.96	8.37	7.83	7.29
Buildings	-	425.78	61.2	43.52	43.52	43.52
Machinery	-	297.7	219	171.07	119.58	83.48
Construction In Progress	-	89.86	386.1	286.09	61.62	2.63
Leasehold Improvements	-	122.8	83.41	46.57	42.45	36.35

Source: S&P Capital IQ. Standard template. Financial Sources.